P-ISSN 2587-2400 | E-ISSN 2587-196X
Ejmo Kapak
EJMO Volume : 8 Issue : 3 Year : 2024
COVID-19 in EJMO 8/3EJMO Current Issue EJMO Archive EJMO & Congress Most Cited Articles Ahead of Print
Copyright Transfer Form
ICMJE COI Form

Volume: 5 Issue: 1 - 2021

REVIEW
Interleukin-2 Level for Normal People and COVID-19 Infection: Is It Our Concern is COVID-19 Infection or Interleukin-2 Level Before the Infection?
Alqaisy Yazan
doi: 10.14744/ejmo.2020.67429   Pages  1 -  5 
(Viewed: 5260)
Multisystemic Long-Term Sequelae of Covid-19: A Review Based on the Current Literature Over a Year of Pandemic Experience
Ahmet Riza Sahin, Burhan Fatih Kocyigit, Ekrem Aksu, Burcu Akkok, Ali Muhittin Tasdogan, Murat Sahin, Mahmut Egemen Senel, Hilmi Erdem Sunbul, Erdinc Gulumsek, Mahmut Buyuksimsek, Deniz Tuncel, Hamza Sahin, Ramazan Azim Okyay, Aysegul Erdogan, Lutfiye Ozpak, Ahmet Acipayam, Celaleddin Turgut, Ismet Cengic, Dogan Cakan, Semih Usaklioglu, Mehmet Kutlu Demirkol, Omer Mert, Abdullah Tok, Abdullah Beyoglu, Rasit Dilek, Ali Mesen, Selma Ates
doi: 10.14744/ejmo.2021.69960   Pages  6 -  19 
(Viewed: 4759)
Psychiatric Disorders and Symptoms in Children and Adolescents During the COVID-19 Pandemic: A Review
Melike Kevser Gul, Esra Demirci
doi: 10.14744/ejmo.2021.14105   Pages  20 -  36 
(Viewed: 4969)
RESEARCH ARTICLE
Association Between Macrophages with Angiogenic Cells and Microvascular Dysfunction in Astrocytic Glioma
Priscilla Das, Nyi Nyi Naing, Nadiah Wan-Arfah, Kon Noorjan, Kantha Rasalingam
doi: 10.14744/ejmo.2021.79703   Pages  37 -  42 
(Viewed: 1788)
Estimation of Death and Recovery Rates using Covid-19 Data of Pakistan
Muhammad Kashif, Rimsha Nasir, Hafiza Nida, Muhammad Imran Khan
doi: 10.14744/ejmo.2021.89947   Pages  43 -  53 
(Viewed: 1625)
Estimation of epidemiological indicators of COVID-19 in Algeria with an SIRD model
Mohamed Lounis, Marwan Al-Raeei
doi: 10.14744/ejmo.2021.35428   Pages  54 -  58 
(Viewed: 2050)
Cost-Effectiveness of Pembrolizumab in Combination with Platinum-Based Chemotherapy in First-Line for Squamous and Nonsquamous Non Small-Cell Lung Cancer. Far from Economic Sustainability
Jacopo Giuliani, Andrea Bonetti
doi: 10.14744/ejmo.2021.96518   Pages  59 -  62 
(Viewed: 1730)
A Comparative Study on Ivermectin-Doxycycline and Hydroxychloroquine-Azithromycin Therapy on COVID-19 Patients
Abu Taiub Mohammed Mohiuddin Chowdhury, Mohammad Shahbaz, Md. Rezaul Karim, Jahirul Islam, Guo Dan, He Shuixiang
doi: 10.14744/ejmo.2021.16263   Pages  63 -  70 
(Viewed: 23105)
In-vitro Evaluation of Effects of Mesenchymal Stem Cells on TLR3, TLR7/8 and TLR9-activated Natural Killer Cells
Alper Tunga Ozdemir, Cengiz Kirmaz, Rabia Bilge Ozgül Ozdemir, Papatya Degirmenci, Mustafa Oztatlici, Mustafa Degirmenci
doi: 10.14744/ejmo.2021.15684   Pages  71 -  79 
(Viewed: 1661)
CASE REPORT
Alpha Fetoprotein Secreting Mucinous Epithelial Ovarian Carcinoma in a Young Woman- a Rare Case Report and Review of Literature
Sangam Jha, Jayanti Sinha, Shreekant Bharti
doi: 10.14744/ejmo.2020.03511   Pages  80 -  84 
(Viewed: 2510)
SHORT COMMUNİCATİON
Psychological effects of Post-Quarantine Following Outbreak of “COVID-19“
Mohammad Abu Shaphe, Aksh Chahal, Mohammed Qasheesh, Rashid Ali Beg
doi: 10.14744/ejmo.2021.70614   Pages  85 -  87 
(Viewed: 1634)
LETTER TO THE EDITOR
Pyloroplasty and Esophageal Surgery: The Sunset Has Come
Mirko Barone, Massimo Ippoliti, Decio Di Nuzzo, Giuseppe Cipollone, Felice Mucilli
doi: 10.14744/ejmo.2021.85881   Pages  88 -  90 
(Viewed: 1390)
Neurotropism of SARS-CoV 2 and others Coronavirus in Children: Mechanisms and Clinical Manifestations
Silvia Marino, Rosaria Taibi, Piero Pavone, Lidia Marino, Raffaele Falsaperla
doi: 10.14744/ejmo.2021.78845   Pages  91 -  93 
(Viewed: 2452)

Submit Manuscript
WEB OF SCIENCE click

  • Impact Factor: 2.5

  • Medicine, General & Internal: Q2 146/322


    • SCOPUS click

  • CiteScoreTracker 2023: 3.6
  • CiteScore year 2022:
    0.9
  • CiteScore year 2021:
    0.2


    • Google Scholar click

  • Number of Articles:315
  • Citations:2587
  • h-index:16
  • i10-index:=26

  • EJMO NLM ID: 101720527

  • Accept Ratio :18.2 %
  • Final decision avg 34 day

    • Copyright © 2024 Eurasian Journal of Medicine and Oncology, EJMO

    EJMO & EJMO